The Uncompetitive N-methyl-D-Aspartate Antagonist Memantine Reduces Binge-Like Eating, Food-Seeking Behavior, and Compulsive Eating: Role of the Nucleus Accumbens Shell

Neuropsychopharmacology

Volumn 40, Issue , 2015, Pages 1163-1171

  Smith, Karen L ^a   Rao, Rahul R ^a   Velázquez Sánchez, Clara ^a   Valenza, Marta ^a   Giuliano, Chiara ^b   Everitt, Barry J ^b   Sabino, Valentina ^a   Cottone, Pietro ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEMANTINE; AMINO ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ARTICLE; BINGE EATING DISORDER; CONFLICT TEST; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; EATING HABIT; FOOD INTAKE; MALE; NONHUMAN; NUCLEUS ACCUMBENS CORE; NUCLEUS ACCUMBENS SHELL; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; TREATMENT RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; COMPULSION; COMPULSIVE EATING; DRUG SELF ADMINISTRATION; EATING DISORDER; FEEDING BEHAVIOR; FOOD SEEKING BEHAVIOR; LIGHT-DARK TEST; PSYCHOPHARMACOLOGY; REINFORCEMENT; ANIMAL; ANIMAL FOOD; ANTAGONISTS AND INHIBITORS; BINGE-EATING DISORDER; COMPULSIVE BEHAVIOR; CONFLICT; DISEASE MODEL; DRUG EFFECTS; EATING; ILLUMINATION; INSTRUMENTAL CONDITIONING; METABOLISM; MOTIVATION; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMAL FEED; ANIMALS; BINGE-EATING DISORDER; COMPULSIVE BEHAVIOR; CONDITIONING, OPERANT; CONFLICT (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; EXCITATORY AMINO ACID ANTAGONISTS; FASTING; FEEDING BEHAVIOR; LIGHTING; MALE; MEMANTINE; MOTIVATION; NUCLEUS ACCUMBENS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; REINFORCEMENT SCHEDULE;

EID: 84925506920     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.299     Document Type: Article

References (52)

1. APA (2013). Diagnostic and Statistical Manual of Mental Disorders. 5th edn. American Psychiatric Association.
2. Avena NM, Rada P, Hoebel BG (2008). Evidence for sugar addiction: Behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 32: 20-39.
3. Bisaga A, Danysz W, Foltin RW (2008). Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder. Eur Neuropsychopharmacol 18: 794-802.
4. Blasio A, Steardo L, Sabino V, Cottone P (2014). Opioid system in the medial prefrontal cortex mediates binge-like eating. Addict Biol 19: 652-662.
5. Blokhina EA, Kashkin VA, Zvartau EE, Danysz W, Bespalov AY (2005). Effects of nicotinic and NMDA receptor channel blockers on intravenous cocaine and nicotine self-administration in mice. Eur Neuropsychopharmacol 15: 219-225.
6. Brennan BP, Roberts JL, Fogarty KV, Reynolds KA, Jonas JM, Hudson JI (2008). Memantine in the treatment of binge eating disorder: an open-label, prospective trial. Int J Eat Disord 41: 520-526.
7. Brog JS, Salyapongse A, Deutch AY, Zahm DS (1993). The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum: immunohistochemical detection of retrogradely transported fluoro-gold. J Comp Neurol 338: 255-278.
8. Carr KD (2007). Chronic food restriction: enhancing effects on drug reward and striatal cell signaling. Physiol Behav 91: 459-472.
9. Corwin RL (2006). Bingeing rats: a model of intermittent excessive behavior? Appetite 46: 11-15.
10. Cottone P, Iemolo A, Narayan AR, Kwak J, Momaney D, Sabino V (2013). The uncompetitive NMDA receptor antagonists ketamine and memantine preferentially increase the choice for a small, immediate reward in low-impulsive rats. Psychopharmacology (Berl) 226: 127-138.
11. Cottone P, Sabino V, Steardo L, Zorrilla EP (2008a). Intermittent access to preferred food reduces the reinforcing efficacy of chow in rats. Am J Physiol 295: R1066-R1076.
12. Cottone P, Sabino V, Steardo L, Zorrilla EP (2008b). Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food. Neuropsychopharmacology 33: 524-535.
13. Cottone P, Sabino V, Steardo L, Zorrilla EP (2009). Consummatory, anxiety-related and metabolic adaptations in female rats with alternating access to preferred food. Psychoneuroendocrinology 34: 38-49.
14. Cottone P, Wang X, Park JW, Valenza M, Blasio A, Kwak J et al (2012). Antagonism of sigma-1 receptors blocks compulsive-like eating. Neuropsychopharmacology 37: 2593-2604.
15. D'Cunha TM, Sedki F, Macri J, Casola C, Shalev U (2013). The effects of chronic food restriction on cue-induced heroin seeking in abstinent male rats. Psychopharmacology (Berl) 225: 241-250.
16. Dore R, Iemolo A, Smith KL, Wang X, Cottone P, Sabino V (2013). CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP. Neuropsychopharmacology 38: 2160-2169.
17. Dore R, Valenza M, Wang X, Rice KC, Sabino V, Cottone P (2014). The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food. Addict Biol 19: 849-861.
18. Everitt BJ, Robbins TW (2000). Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour. Psychopharmacology (Berl) 153: 17-30.
19. Foltin RW, Danysz W, Bisaga A (2008). A novel procedure for assessing the effects of drugs on satiation in baboons: effects of memantine and dexfenfluramine. Psychopharmacology (Berl) 199: 583-592.
20. Gass JT, Olive MF (2008). Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol 75: 218-265.
21. Ghaleiha A, Entezari N, Modabbernia A, Najand B, Askari N, Tabrizi M et al (2013). Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study. J Psychiatr Res 47: 175-180.
22. Giuliano C, Robbins TW, Nathan PJ, Bullmore ET, Everitt BJ (2012). Inhibition of opioid transmission at the mu-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacology 37: 2643-2652.
23. Grant JE, Odlaug BL, Mooney M, O'Brien R, Kim SW (2012). Open-label pilot study of memantine in the treatment of compulsive buying. Ann Clin Psychiatry 24: 119-126.
24. Hart CL, Haney M, Foltin RW, Fischman MW (2002). Effects of the NMDA antagonist memantine on human methamphetamine discrimination. Psychopharmacology (Berl) 164: 376-384.
25. Hermanussen M, Tresguerres JA (2005). A new anti-obesity drug treatment: first clinical evidence that, antagonising glutamategated Ca2+ ion channels with memantine normalises bingeeating disorders. Econ Hum Biol 3: 329-337.
26. Hyytia P, Backstrom P, Liljequist S (1999). Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats. Eur J Pharmacol 378: 9-16.
27. Iemolo A, Blasio A, St Cyr SA, Jiang F, Rice KC, Sabino V et al (2013). CRF-CRF1 receptor system in the central and basolateral nuclei of the amygdala differentially mediates excessive eating of palatable food. Neuropsychopharmacology 38: 2456-2466.
28. Kalivas PW, Volkow N, Seamans J (2005). Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 45: 647-650.
29. Kalivas PW, Volkow ND (2011). New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry 16: 974-986.
30. Kelleher RT, Goldberg SR (1977). Fixed-interval responding under second-order schedules of food presentation or cocaine injection. J Exp Anal Behav 28: 221-231.
31. Kessler RC, Berglund PA, Chiu WT, Deitz AC, Hudson JI, Shahly V et al (2013). The prevalence and correlates of binge eating disorder in the world health organization world mental health surveys. Biol Psychiatry 73: 904-914.
32. Koltunowska D, Gibula-Bruzda E, Kotlinska JH (2013). The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats. Prog Neuropsychopharmacol Biol Psychiatry 45: 242-249.
33. Maldonado-Irizarry CS, Swanson CJ, Kelley AE (1995). Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J Neurosci 15: 6779-6788.
34. McGeorge AJ, Faull RL (1989). The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29: 503-537.
35. Micioni Di Bonaventura MV, Ciccocioppo R, Romano A, Bossert JM, Rice KC, Ubaldi M et al (2014). Role of bed nucleus of the stria terminalis corticotrophin-releasing factor receptors in frustration stress-induced binge-like palatable food consumption in female rats with a history of food restriction. J Neurosci 34: 11316-11324.
36. Minkeviciene R, Banerjee P, Tanila H (2008). Cognition-enhancing and anxiolytic effects of memantine. Neuropharmacology 54: 1079-1085.
37. Nemeth CL, Paine TA, Rittiner JE, Beguin C, Carroll FI, Roth BL et al (2010). Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats. Psychopharmacology (Berl) 210: 263-274.
38. Ng L, Davis C (2013). Cravings and food consumption in Binge Eating Disorder. Eat Behav 14: 472-475.
39. Paine TA, Carlezon WA Jr (2009). Effects of antipsychotic drugs on MK-801-induced attentional and motivational deficits in rats. Neuropharmacology 56: 788-797.
40. Parylak SL, Cottone P, Sabino V, Rice KC, Zorrilla EP (2012). Effects of CB1 and CRF1 receptor antagonists on binge-like eating in rats with limited access to a sweet fat diet: lack of withdrawal-like responses. Physiol Behav 107: 231-242.
41. Popik P, Kos T, Zhang Y, Bisaga A (2011). Memantine reduces consumption of highly palatable food in a rat model of binge eating. Amino Acids 40: 477-485.
42. Popik P, Wrobel M, Rygula R, Bisaga A, Bespalov AY (2003). Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice. Behav Pharmacol 14: 237-244.
43. Reynolds SM, Berridge KC (2003). Glutamate motivational ensembles in nucleus accumbens: rostrocaudal shell gradients of fear and feeding. Eur J Neurosci 17: 2187-2200.
44. Sabino V, Cottone P, Steardo L, Schmidhammer H, Zorrilla EP (2007). 14-Methoxymetopon, a highly potent mu opioid agonist, biphasically affects ethanol intake in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) 192: 537-546.
45. Sabino V, Narayan AR, Zeric T, Steardo L, Cottone P (2013). mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats. Behav Brain Res 247: 9-16.
46. Schenk S, Valadez A, Worley CM, McNamara C (1993). Blockade of the acquisition of cocaine self-administration by the NMDA antagonist MK-801 (dizocilpine). Behav Pharmacol 4: 652-659.
47. Semenova S, Danysz W, Bespalov A (1999). Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice. Eur J Pharmacol 378: 1-8.
48. Smith JW, Gastambide F, Gilmour G, Dix S, Foss J, Lloyd K et al (2011). A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory. Psychopharmacology (Berl) 217: 255-269.
49. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK et al (2010). Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62: 405-496.
50. Velazquez-Sanchez C, Ferragud A, Moore CF, Everitt BJ, Sabino V, Cottone P (2014). High trait impulsivity predicts food addiction-like behavior in the rat. Neuropsychopharmacology 39: 2463-2472.
51. Yang Z, Zhou X, Zhang Q (2013). Effectiveness and safety of memantine treatment for Alzheimer's disease. J Alzheimers Dis 36: 445-458.
52. Zahm DS, Brog JS (1992). On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience 50: 751-767.